HK1027041A1 - Method for detection of fibrin clots - Google Patents

Method for detection of fibrin clots

Info

Publication number
HK1027041A1
HK1027041A1 HK00106358.3A HK00106358A HK1027041A1 HK 1027041 A1 HK1027041 A1 HK 1027041A1 HK 00106358 A HK00106358 A HK 00106358A HK 1027041 A1 HK1027041 A1 HK 1027041A1
Authority
HK
Hong Kong
Prior art keywords
detection
source
fibrin
particles
fibrin clots
Prior art date
Application number
HK00106358.3A
Other languages
English (en)
Inventor
Chenicheri Hariharan Nair
Elena Alexandra Shats
William Martin Burch
Rodney James Browitt
Timothy John Senden
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Publication of HK1027041A1 publication Critical patent/HK1027041A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
HK00106358.3A 1997-07-24 2000-10-09 Method for detection of fibrin clots HK1027041A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/AU1997/000467 WO1999004826A1 (fr) 1997-07-24 1997-07-24 Procede de detection de caillots fibrineux
PCT/AU1998/000582 WO1999004827A1 (fr) 1997-07-24 1998-07-23 Procede de detection de caillots de fibrine

Publications (1)

Publication Number Publication Date
HK1027041A1 true HK1027041A1 (en) 2001-01-05

Family

ID=3764343

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106358.3A HK1027041A1 (en) 1997-07-24 2000-10-09 Method for detection of fibrin clots

Country Status (9)

Country Link
US (1) US6977068B1 (fr)
EP (1) EP1027080B1 (fr)
JP (1) JP3943330B2 (fr)
AT (1) ATE488253T1 (fr)
AU (2) AU3532197A (fr)
CA (1) CA2297399C (fr)
DE (1) DE69842003D1 (fr)
HK (1) HK1027041A1 (fr)
WO (2) WO1999004826A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3532197A (en) 1997-07-24 1999-02-16 Australian National University, The Method for detection of fibrin clots
WO2000078362A2 (fr) * 1999-06-22 2000-12-28 Aventis Research & Technologies Gmbh & Co. Kg Nanoparticules stables, marquees de maniere radioactive, leur procede de production et leur utilisation
US6689338B2 (en) * 2000-06-01 2004-02-10 The Board Of Regents For Oklahoma State University Bioconjugates of nanoparticles as radiopharmaceuticals
US8778300B2 (en) 2005-04-29 2014-07-15 The Australian National University Method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
AU2006243805B2 (en) * 2005-04-29 2012-02-02 The Australian National University A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
AU2006200755B2 (en) * 2005-07-11 2011-02-10 Cyclomedica Australia Pty Limited Improved process for the production of a radioactive aerosol
EP2282782B1 (fr) * 2008-04-24 2018-01-24 The Australian National University Procedes de radiomarquage de macromolecules
US9381262B2 (en) 2008-04-24 2016-07-05 The Australian National University Methods for radiolabeling synthetic polymers
DE102009015792A1 (de) * 2009-03-23 2010-09-30 Technische Universität Dresden Mittel für die Diagnose der Lungenfunktion mittels Positronen-Emissions-Tomographie
GB0922497D0 (en) * 2009-12-23 2010-02-03 Hammersmith Imanet Ltd Preparation and use of 68GA labelled particles
CN103402526B (zh) 2010-12-01 2016-01-20 澳大利亚国立大学 组蛋白抑制
WO2013022796A2 (fr) 2011-08-05 2013-02-14 Silk Road Medical, Inc. Procédés et systèmes de traitement d'un accident ischémique cérébral aigu
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
ES2770321T3 (es) 2015-02-04 2020-07-01 Route 92 Medical Inc Sistema de trombectomía por aspiración rápida
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
WO2017019563A1 (fr) 2015-07-24 2017-02-02 Route 92 Medical, Inc. Système et procédés de distribution d'ancrage
CN113350655B (zh) 2016-02-24 2024-03-19 禾木（中国）生物工程有限公司 柔性增强的神经血管导管
WO2018129194A1 (fr) 2017-01-06 2018-07-12 Incept, Llc Revêtements thromborésistants pour dispositifs de traitement d'anévrisme
EP3568186B1 (fr) 2017-01-10 2022-09-14 Route 92 Medical, Inc. Systèmes de cathéters d'aspiration
CA3095844A1 (fr) 2018-05-01 2019-11-07 Incept, Llc Dispositifs et procedes de retrait de materiau obstructif d'un site intravasculaire
US11395665B2 (en) 2018-05-01 2022-07-26 Incept, Llc Devices and methods for removing obstructive material, from an intravascular site
JP2021523793A (ja) 2018-05-17 2021-09-09 ルート９２メディカル・インコーポレイテッドＲｏｕｔｅ ９２ Ｍｅｄｉｃａｌ， Ｉｎｃ． 吸引カテーテルシステム及び使用方法
US11471582B2 (en) 2018-07-06 2022-10-18 Incept, Llc Vacuum transfer tool for extendable catheter
WO2020010310A1 (fr) 2018-07-06 2020-01-09 Imperative Care, Inc. Cathéter neurovasculaire extensible étanche
US11766539B2 (en) 2019-03-29 2023-09-26 Incept, Llc Enhanced flexibility neurovascular catheter
EP4044906A4 (fr) 2019-10-15 2023-05-24 Imperative Care, Inc. Systèmes et procédés de détection d'attaque multivariable
US11553935B2 (en) 2019-12-18 2023-01-17 Imperative Care, Inc. Sterile field clot capture module for use in thrombectomy system
CN113365687A (zh) 2019-12-18 2021-09-07 因普瑞缇夫护理公司 治疗静脉血栓栓塞疾病的方法和***
US11259821B2 (en) 2019-12-18 2022-03-01 Imperative Care, Inc. Aspiration system with accelerated response
EP4117762A4 (fr) 2020-03-10 2024-05-08 Imperative Care Inc Cathéter neurovasculaire à flexibilité améliorée
US11207497B1 (en) 2020-08-11 2021-12-28 Imperative Care, Inc. Catheter with enhanced tensile strength

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84427T1 (de) * 1984-10-04 1993-01-15 I J & L A Tetley Manufacturing Geraet zur erzeugung eines gasgemisches fuer diagnostische zwecke.
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
GB9203037D0 (en) * 1992-02-11 1992-03-25 Salutar Inc Contrast agents
CA2147129A1 (fr) * 1992-10-27 1994-05-11 James B. Doherty Nouvelles azetidinones substituees utilisees comme agents anti-inflammatoires et anti-degeneratifs
AU686861B2 (en) * 1994-09-21 1998-02-12 Allrad No. 28 Pty Ltd A precipitator
DE19506188C2 (de) * 1995-02-22 2003-03-06 Miladin Lazarov Implantat und dessen Verwendung
US5640705A (en) * 1996-01-16 1997-06-17 Koruga; Djuro L. Method of containing radiation using fullerene molecules
AU3532197A (en) * 1997-07-24 1999-02-16 Australian National University, The Method for detection of fibrin clots

Also Published As

Publication number Publication date
WO1999004826A1 (fr) 1999-02-04
JP2001510812A (ja) 2001-08-07
ATE488253T1 (de) 2010-12-15
JP3943330B2 (ja) 2007-07-11
AU8425998A (en) 1999-02-16
US6977068B1 (en) 2005-12-20
DE69842003D1 (de) 2010-12-30
EP1027080A1 (fr) 2000-08-16
CA2297399A1 (fr) 1999-02-04
AU3532197A (en) 1999-02-16
AU744489B2 (en) 2002-02-28
CA2297399C (fr) 2007-07-03
EP1027080B1 (fr) 2010-11-17
WO1999004827A1 (fr) 1999-02-04
EP1027080A4 (fr) 2004-07-14

Similar Documents

Publication Publication Date Title
HK1027041A1 (en) Method for detection of fibrin clots
AU6545898A (en) Method for identifying hormonally modulated genes
HK1017124A1 (en) Hybrid disc and method for discriminating same.
GB9800239D0 (en) Methods and systems for biological reagent placement
EP0807800A4 (fr) Systeme de detection de coordonnees, procede associe et appareil de jeu
AU8112898A (en) Method for identifying and/or analysing biological substances, present in a conductive liquid, device and affinity sensor used for implementing said method
EP0730154A4 (fr) Inhibiteur d'adherence des facteurs sanguins, accelerateur de coagulation sanguine, procede d'utilisation de ces agents, et recipient et support pour examens sanguins
HK1029032A1 (en) Method and arrangement for blood pressure measurement
AU7819198A (en) System and method for sorting program guide information
DE69017636D1 (de) Detektierbarer Gegenstand zur unterirdischen Anwendung und Verfahren zu seiner Lokalisierung.
AU1677300A (en) A system and method for detecting, localizing, and characterizing occlusions andaneurysms in a vessel
GR3034647T3 (en) Test article and method for performing blood coagulation assays.
ZA9710879B (en) Method and apparatus for acquiring a pilot signal in a CDMA receiver.
ZA200201350B (en) Method of trasferring files and analysis of train operational data.
DE69720910T2 (de) System und Methode zur Sammlung von Informationen
PL325686A1 (en) Fully automatic method of rapidly identifying and charaterising reticulocytes, erythrocytes and thrombocytes in whole blood and composition of a reagent used therefor
HK1032167A1 (en) Additional information embedding method, addition al information detecting method, additional information embedding apparatus and additional information detecting apparatus.
EP0998582A4 (fr) Procedes de diagnostic et de traitement du cancer, et procedes d'identification de marqueurs pathogenes dans un echantillon de cellules normales
EP1004674A4 (fr) Proteine adamts-1 humaine, gene codant pour cette proteine, composition pharmaceutique et procede de dosage immunologique de proteine adamts-1 humaine
AU1350501A (en) Methods and devices for identifying patterns in biological systems and methods for uses thereof
AU7104498A (en) Method and apparatus for collecting blood
AU4974297A (en) Method and apparatus for determining indirectly the concentration of a specific substance in the blood
HK1023830A1 (en) Method for identifying a plurality of transponders, analysing device and transponders for implementing said method.
DE69709087D1 (de) Verfahren zum nachweis und zur identifizierung von mikroorganismen
ZA97825B (en) Method and system for identifying at risk patients diagnosed with depression.

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20180722